vs
Side-by-side financial comparison of GREENE COUNTY BANCORP INC (GCBC) and Entrada Therapeutics, Inc. (TRDA). Click either name above to swap in a different company.
GREENE COUNTY BANCORP INC is the larger business by last-quarter revenue ($22.2M vs $20.6M, roughly 1.1× Entrada Therapeutics, Inc.). GREENE COUNTY BANCORP INC runs the higher net margin — 46.3% vs -84.4%, a 130.7% gap on every dollar of revenue. On growth, GREENE COUNTY BANCORP INC posted the faster year-over-year revenue change (23.8% vs -65.2%). GREENE COUNTY BANCORP INC produced more free cash flow last quarter ($6.2M vs $-39.7M). Over the past eight quarters, GREENE COUNTY BANCORP INC's revenue compounded faster (18.9% CAGR vs 6.4%).
Bank of Greene County is an American federally-chartered savings bank headquartered in Catskill, NY. The bank's branches are located in the Upstate New York counties of Greene, Columbia, Albany, Ulster, and Rensselaer.
Entrada Therapeutics is a clinical-stage biotechnology firm developing transformative intracellular therapies for serious rare diseases and high-unmet-need disorders. Its pipeline covers neuromuscular, metabolic, and central nervous system segments, serving global patients via healthcare partnerships.
GCBC vs TRDA — Head-to-Head
Income Statement — Q2 FY2026 vs Q1 FY2025
| Metric | | |
|---|---|---|
| Revenue | $22.2M | $20.6M |
| Net Profit | $10.3M | $-17.3M |
| Gross Margin | — | — |
| Operating Margin | 52.0% | -106.0% |
| Net Margin | 46.3% | -84.4% |
| Revenue YoY | 23.8% | -65.2% |
| Net Profit YoY | 37.4% | -173.8% |
| EPS (diluted) | $0.60 | $-0.42 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $22.2M | — | ||
| Q3 25 | $21.5M | — | ||
| Q2 25 | $20.5M | — | ||
| Q1 25 | $20.1M | $20.6M | ||
| Q4 24 | $17.9M | $37.4M | ||
| Q3 24 | $16.9M | $19.6M | ||
| Q2 24 | $16.6M | $94.7M | ||
| Q1 24 | $15.7M | $59.1M |
| Q4 25 | $10.3M | — | ||
| Q3 25 | $8.9M | — | ||
| Q2 25 | $9.3M | — | ||
| Q1 25 | $8.1M | $-17.3M | ||
| Q4 24 | $7.5M | $1.1M | ||
| Q3 24 | $6.3M | $-14.0M | ||
| Q2 24 | $6.7M | $55.0M | ||
| Q1 24 | $5.9M | $23.5M |
| Q4 25 | 52.0% | — | ||
| Q3 25 | 47.4% | — | ||
| Q2 25 | 53.5% | — | ||
| Q1 25 | 44.6% | -106.0% | ||
| Q4 24 | 45.0% | -15.7% | ||
| Q3 24 | 39.6% | -110.7% | ||
| Q2 24 | 41.2% | 56.4% | ||
| Q1 24 | 39.4% | 35.7% |
| Q4 25 | 46.3% | — | ||
| Q3 25 | 41.2% | — | ||
| Q2 25 | 45.6% | — | ||
| Q1 25 | 40.1% | -84.4% | ||
| Q4 24 | 41.7% | 3.0% | ||
| Q3 24 | 37.1% | -71.7% | ||
| Q2 24 | 40.6% | 58.1% | ||
| Q1 24 | 37.3% | 39.7% |
| Q4 25 | $0.60 | — | ||
| Q3 25 | $0.52 | — | ||
| Q2 25 | $0.55 | — | ||
| Q1 25 | $0.47 | $-0.42 | ||
| Q4 24 | $0.44 | $-0.20 | ||
| Q3 24 | $0.37 | $-0.35 | ||
| Q2 24 | $0.39 | $1.55 | ||
| Q1 24 | $0.34 | $0.68 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $67.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $258.3M | $417.3M |
| Total Assets | $3.1B | $486.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $155.5M | $67.8M | ||
| Q4 24 | $166.4M | $101.2M | ||
| Q3 24 | — | $78.0M | ||
| Q2 24 | $190.4M | $185.3M | ||
| Q1 24 | — | $68.4M |
| Q4 25 | $258.3M | — | ||
| Q3 25 | $248.2M | — | ||
| Q2 25 | $238.8M | — | ||
| Q1 25 | $229.0M | $417.3M | ||
| Q4 24 | $218.4M | $428.7M | ||
| Q3 24 | $216.3M | $422.4M | ||
| Q2 24 | $206.0M | $429.9M | ||
| Q1 24 | $199.2M | $269.4M |
| Q4 25 | $3.1B | — | ||
| Q3 25 | $3.1B | — | ||
| Q2 25 | $3.0B | — | ||
| Q1 25 | $3.0B | $486.5M | ||
| Q4 24 | $3.0B | $526.3M | ||
| Q3 24 | $2.9B | $554.6M | ||
| Q2 24 | $2.8B | $582.0M | ||
| Q1 24 | $2.9B | $510.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $6.4M | $-38.5M |
| Free Cash FlowOCF − Capex | $6.2M | $-39.7M |
| FCF MarginFCF / Revenue | 28.0% | -192.9% |
| Capex IntensityCapex / Revenue | 0.9% | 5.6% |
| Cash ConversionOCF / Net Profit | 0.62× | — |
| TTM Free Cash FlowTrailing 4 quarters | $47.3M | $-58.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $6.4M | — | ||
| Q3 25 | $7.0M | — | ||
| Q2 25 | $28.0M | — | ||
| Q1 25 | $7.3M | $-38.5M | ||
| Q4 24 | $5.3M | $-31.6M | ||
| Q3 24 | $2.1M | $-24.3M | ||
| Q2 24 | $24.9M | $39.8M | ||
| Q1 24 | $5.6M | $-25.5M |
| Q4 25 | $6.2M | — | ||
| Q3 25 | $6.5M | — | ||
| Q2 25 | $27.3M | — | ||
| Q1 25 | $7.3M | $-39.7M | ||
| Q4 24 | $5.1M | $-32.2M | ||
| Q3 24 | $2.0M | $-24.9M | ||
| Q2 24 | $23.4M | $38.8M | ||
| Q1 24 | $4.9M | $-26.4M |
| Q4 25 | 28.0% | — | ||
| Q3 25 | 30.4% | — | ||
| Q2 25 | 133.3% | — | ||
| Q1 25 | 36.1% | -192.9% | ||
| Q4 24 | 28.6% | -86.2% | ||
| Q3 24 | 11.8% | -127.3% | ||
| Q2 24 | 141.2% | 41.0% | ||
| Q1 24 | 31.3% | -44.6% |
| Q4 25 | 0.9% | — | ||
| Q3 25 | 1.9% | — | ||
| Q2 25 | 3.4% | — | ||
| Q1 25 | 0.3% | 5.6% | ||
| Q4 24 | 1.0% | 1.7% | ||
| Q3 24 | 0.9% | 3.3% | ||
| Q2 24 | 9.1% | 1.1% | ||
| Q1 24 | 4.2% | 1.4% |
| Q4 25 | 0.62× | — | ||
| Q3 25 | 0.78× | — | ||
| Q2 25 | 3.00× | — | ||
| Q1 25 | 0.91× | — | ||
| Q4 24 | 0.71× | -27.94× | ||
| Q3 24 | 0.34× | — | ||
| Q2 24 | 3.70× | 0.72× | ||
| Q1 24 | 0.95× | -1.09× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
